… Therefore, inhibition of these matrix metalloproteinases functions in IPF is a potential
therapeutic approach. In addition to the use of synthetic inhibitor, various natural compounds, gene …

… Another approach was to … therapeutic approaches has failed to establish its beneficial role
in the management of IPF. This is possibly due to the fact that none of the above therapeutic …

… of pulmonary fibrosis by anti-inflammatory therapy. Thus, the main cause of pulmonary
fibrosis is not inflammation, but inflammation has the possibility of developing fibrosis [6], [19]. …

… pulmonary fibrosis is … of fibrosis that show promise in experimental and clinical studies. In
the remainder of this review we shall look at the various phases of fibrosis and the therapeutic …

… Although the above therapeutic approaches were efficient in animal models, the humans
could develop immune reactions against the antibodies or auto-immune-like disorders. …

… pulmonary fibrosis (IPF) is a chronic, progressive, fibrotic lung disease with no clear etiology
and few therapeutic … of this disease might be important therapeutic targets. Nintedanib is a …

… In addition, we discuss current and potential future therapeutic approaches for this age-related
lung disease. The epidemiology, clinical presentation and diagnosis of IPF have recently …

… of pulmonary fibrosis and has issued a summary statement of a recent workshop directed at
reviewing approaches … regarding novel therapies for pulmonary fibrosis including antifibrotic …

… therapies that improve survival. The application of omics technologies has revolutionized
our approach to identifying previously unknown therapeutic … new therapeutic approaches, …

… The belief that the development and progression of IPF were driven by uncontrolled inflammation
underpins what has, until only recently, been the standard therapeutic approach for IPF…